CRESPONSE
Dead / Abandoned — Abandoned — no statement of use filed (as of 15 Jul 2024)
What this means for you
This application is over — abandoned 15 Jul 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90170301
- Mark type
- Stylized text
- Filed
- 10 Sept 2020
- Published for opposition
- 13 Apr 2021
- Abandoned
- 15 Jul 2024
- Attorney of record
- Abigail Rubinstein
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic testing materials, namely, specialized tissue culture medical purposes; medical diagnostic reagents and assays for testing of tissue cultures and biological cultures; medical diagnostic reagents and assays for testing of body fluids; diagnostic test reagents for medical use for testing human cancer tissue; biological preparations for diagnostic purposes for medical purposes; diagnostic agents for medical and pharmaceutical purposes; diagnostic substances for medical purposes; medical diagnostic test strips for cancer analysis; diagnostic kits comprising of medical diagnostic agents, preparations and substances for medical purposes, namely, predicting response to cancer treatment; diagnostic biomarker reagents for medical purposes; in vitro diagnostic preparations for medical use; assay samples for medical and pharmaceutical use; biological tissue cultures for medical purposes
- Class 042 — Scientific and technological services: Laboratory testing in the nature of analysis in the field of cancer testing and pathology; medical laboratory services; scientific research for medical purposes in the area of cancerous diseases; pharmaceutical product evaluation; providing testing services and information for diagnosis, prognosis and predictive behavior of cancer for research purposes
Owner
- Curesponse Ltd., Tel Aviv, IL
- Curesponse Ltd., Tel Aviv, IL
Prosecution history
- 15 Jul 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 15 Jul 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 30 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Nov 2023 — SOU EXTENSION 5 GRANTED
- 17 Nov 2023 — SOU EXTENSION 5 FILED
- 29 Nov 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Nov 2023 — SOU TEAS EXTENSION RECEIVED
- 20 May 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 May 2023 — SOU EXTENSION 4 GRANTED
- 18 May 2023 — SOU EXTENSION 4 FILED
- 18 May 2023 — SOU TEAS EXTENSION RECEIVED
- 19 Nov 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Nov 2022 — SOU EXTENSION 3 GRANTED
- 17 Nov 2022 — SOU EXTENSION 3 FILED
- 17 Nov 2022 — SOU TEAS EXTENSION RECEIVED